ACM
VRTX icon

Aquatic Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Aquatic Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-29,596
Closed -$11.6M – 1805
2025
Q3 		$11.6M Buy
+29,596
New +$12.4M 0.22% 116
2023
Q1 		– Sell
-24,600
Closed -$7.1M – 1790
2022
Q4 		$7.1M Buy
+24,600
New +$7.5M 0.52% 31
2022
Q3 		– Sell
-1,000
Closed -$282K – 1587
2022
Q2 		$282K Buy
+1,000
New +$268K 0.09% 266
2022
Q1 		– Sell
-100
Closed -$22K – 1569
2021
Q4 		$22K Buy
+100
New +$19.4K 0.04% 575

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Aquatic Capital Management's VRTX Position: Q4 2025 in Review

Aquatic Capital Management sold out of Vertex Pharmaceuticals (VRTX) in Q4 2025, closing a stake of 29,596 shares — an estimated $11.6M sold.

Aquatic Capital Management first reported a position in VRTX in Q4 2021 and held it in 4 quarters. The position peaked at $11.6M in Q3 2025. 1,668 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.

  • Aquatic Capital Management reported no remaining Vertex Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 29,596 Vertex Pharmaceuticals shares in Q4 2025, an estimated $11.6M.
  • Aquatic Capital Management first reported a position in Vertex Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • Aquatic Capital Management's Vertex Pharmaceuticals position peaked at $11.6M in Q3 2025.
  • 1,668 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.

Based on Aquatic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.